4//SEC Filing
Shmagin Martin E 4
Accession 0001013762-09-000115
CIK 0000932352other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 5:43 PM ET
Size
6.4 KB
Accession
0001013762-09-000115
Insider Transaction Report
Form 4
Urigen Pharmaceuticals, Inc.UGRP.OB
Shmagin Martin E
DirectorChief Financial Officer
Transactions
- Purchase
Common Stock, $.001 Par Value
2009-01-22$0.14/sh−20,000$2,700→ 3,074,073 total - Purchase
Common Stock, $.001 Par Value
2009-01-23$0.16/sh−20,000$3,200→ 3,094,073 total
Documents
Issuer
Urigen Pharmaceuticals, Inc.
CIK 0000932352
Entity typeother
Related Parties
1- filerCIK 0001407236
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 5:43 PM ET
- Size
- 6.4 KB